Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

Good Connection: Uplifting stories for a digital age Creator Playbook Trending Now Say More Look Up Mashable's Best: E-readers, robovacs, laptops, earbuds, smart home and more Switch Off Mashable Voices Mashable Selects Safety Net Versus Gift Ideas For Everyone On Your List All Series'I get so upset and frustrated': What dating is like on a GLP-1 Finding a partner after weight loss might be even harder. Anna Iovine is the associate editor of features at Mashable. Previously, as the sex and relationships reporter, she covered topics ranging from dating apps to pelvic pain. Before Mashable, Anna was a social editor at VICE and freelanced for publications such as Slate and the Columbia Journalism Review. Follow her on Bluesky .

How an alliance of tech startups, MAHA operatives, and actual medical experts made millennial women the new face of hormone therapy. Lisa Schrenk didn't know it yet, as she trudged down a dirt trail last August, but her life was about to change. She'd set out late the night before with her hiking group, scrambling up Virginia's Old Rag Mountain in darkness. They reached the peak in time to watch the sun rise over the Blue Ridge range. Afterward, the women snapped photos. In one, Schrenk gazes out over the horizon, her long dark hair pulled into a ponytail. The image is deceptively triumphant. In reality, she had been contemplating suicide. Schrenk, a longtime IT specialist for the federal government, had started setting aside belongings for friends and family, organizing her financial affairs, and clearing out her office.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this author to personalize your feed and get instant alerts.

We smell different as we age. An odor-producing molecule 2-nonenal is only part of the story. More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. There's a scientific explanation behind an aging body's distinct scent, but the chemistry only tells half the story. Breakthroughs, discoveries, and DIY tips sent six days a week.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs. Has anyone tried to sell you peptides yet? Once a niche interest among bodybuilders and biohackers, peptides are an increasingly popular class of substance hyped by both fringe influencers and the current US Secretary of Health and Human Services. Earlier this year, Robert F. Kennedy Jr. told the podcaster Joe Rogan that the government intended to loosen restrictions on peptide production.

Pillay is an editorial fellow at TIME. America's healthcare system is notoriously reactive. Could AI shift it from a system that treats illness to one that prevents it? The question framed a panel discussion at the inaugural TIME100 AI Leadership Forum on May 27, which featured Dr. Omar Lateef, the president and CEO of Rush University System for Health; Arianna Huffington, the founder and CEO of Thrive Global; and Neil Lindsay, senior vice president of Amazon Health Services (Amazon One Medical, an Amazon health service, was an event sponsor). The conversation was moderated by TIME senior health correspondent Alice Park.

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV. A Miracle cancer therapy that involves engineering a patient's own immune cells is being repurposed for HIV, and early results from two individuals hint at its promise for long-term control of the virus. As part of a clinical trial, scientists took people's own immune cells and reprogrammed them in a lab to recognize and attack HIV in the body. After a single infusion of the modified cells, two individuals with HIV now have undetectable levels of the virus--one for nearly two years and the other for almost a year.

As patients and employers look for alternatives to pricey GLP-1 drugs, Silicon Valley startup Twin Health is using AI and wearable sensors to help people make healthier choices. Rodney Buckley has lost 100 pounds in less than a year, not by using a GLP-1 drug but with the help of a digital twin. Last March, the 55-year-old retired firefighter turned village mayor of Third Lake, Illinois, was 376 pounds. He had tried different diets over the years and would typically lose some weight but eventually gain it back. When his wife's employer started offering a program from startup Twin Health, he thought he would give it a try.